Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:27716369

Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association Consortium.

Taru A Muranen · Carl Blomqvist · Thilo Dörk · Anna Jakubowska · Päivi Heikkilä · Rainer Fagerholm · Dario Greco · Kristiina Aittomäki · Stig E Bojesen · Mitul Shah · Alison M Dunning · Valerie Rhenius · Per Hall · Kamila Czene · Judith S Brand · Hatef Darabi · Jenny Chang-Claude · Anja Rudolph · Børge G Nordestgaard · Fergus J Couch · Steven N Hart · Jonine Figueroa · Montserrat García-Closas · Peter A Fasching · Matthias W Beckmann · Jingmei Li · Jianjun Liu · Irene L Andrulis · Robert Winqvist · Katri Pylkäs · Arto Mannermaa · Vesa Kataja · Annika Lindblom · Sara Margolin · Jan Lubinski · Natalia Dubrowinskaja · Manjeet K Bolla · Joe Dennis · Kyriaki Michailidou · Qin Wang · Douglas F Easton · Paul D P Pharoah · Marjanka K Schmidt · Heli Nevanlinna

Breast cancer research : BCR · 2016 doi:10.1186/s13058-016-0758-5

Paper

complete

Experiment

partial

Data

partial

Analysis

complete

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:27716369
kind
science-record
content_hash
sha256:87405e2323f281a6ff7b41f90f56cd6eec39ca96509b1a4cfef82f55dfa454da
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T15:40:20Z
updated_at
2026-11-01T21:20:40Z
generator object · 2 fields
name
corpus-assay-engine
run_id
reading-sci-2026-11-01
paper object · 10 fields
state
complete
title
Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association Consortium.
doi
10.1186/s13058-016-0758-5
pmid
27716369
authors array · 44 items
[0]
Taru A Muranen
[1]
Carl Blomqvist
[2]
Thilo Dörk
[3]
Anna Jakubowska
[4]
Päivi Heikkilä
[5]
Rainer Fagerholm
[6]
Dario Greco
[7]
Kristiina Aittomäki
[8]
Stig E Bojesen
[9]
Mitul Shah
[10]
Alison M Dunning
[11]
Valerie Rhenius
[12]
Per Hall
[13]
Kamila Czene
[14]
Judith S Brand
[15]
Hatef Darabi
[16]
Jenny Chang-Claude
[17]
Anja Rudolph
[18]
Børge G Nordestgaard
[19]
Fergus J Couch
[20]
Steven N Hart
[21]
Jonine Figueroa
[22]
Montserrat García-Closas
[23]
Peter A Fasching
[24]
Matthias W Beckmann
[25]
Jingmei Li
[26]
Jianjun Liu
[27]
Irene L Andrulis
[28]
Robert Winqvist
[29]
Katri Pylkäs
[30]
Arto Mannermaa
[31]
Vesa Kataja
[32]
Annika Lindblom
[33]
Sara Margolin
[34]
Jan Lubinski
[35]
Natalia Dubrowinskaja
[36]
Manjeet K Bolla
[37]
Joe Dennis
[38]
Kyriaki Michailidou
[39]
Qin Wang
[40]
Douglas F Easton
[41]
Paul D P Pharoah
[42]
Marjanka K Schmidt
[43]
Heli Nevanlinna
journal
Breast cancer research : BCR
year
2016
abstract
BACKGROUND: P.I157T is a CHEK2 missense mutation associated with a modest increase in breast cancer risk. Previously, another CHEK2 mutation, the protein truncating c.1100delC has been associated with poor prognosis of breast cancer patients. Here, we have investigated patient survival and characteristics of breast tumors of germ line p.I157T carriers. METHODS: We included in the analyses 26,801 European female breast cancer patients from 15 studies participating in the Breast Cancer Association Consortium. We analyzed the association between p.I157T and the clinico-pathological breast cancer characteristics by comparing the p.I157T carrier tumors to non-carrier and c.1100delC carrier tumors. Similarly, we investigated the p.I157T associated risk of early death, breast cancer-associated death, distant metastasis, locoregional relapse and second breast cancer using Cox proportional hazards models. Additionally, we explored the p.I157T-associated genomic gene expression profile using data from breast tumors of 183 Finnish female breast cancer patients (ten p.I157T carriers) (GEO: GSE24450). Differential gene expression analysis was performed using a moderated t test. Functional enrichment was investigated using the DAVID functional annotation tool and gene set enrichment analysis (GSEA). The tumors were classified into molecular subtypes according to the St Gallen 2013 criteria and the PAM50 gene expression signature. RESULTS: P.I157T was not associated with increased risk of early death, breast cancer-associated death or distant metastasis relapse, and there was a significant difference in prognosis associated with the two CHEK2 mutations, p.I157T and c.1100delC. Furthermore, p.I157T was associated with lobular histological type and clinico-pathological markers of good prognosis, such as ER and PR expression, low TP53 expression and low grade. Gene expression analysis suggested luminal A to be the most common subtype for p.I157T carriers and CDH1 (cadherin 1) target genes to be significantly enriched among genes, whose expression differed between p.I157T and non-carrier tumors. CONCLUSIONS: Our analyses suggest that there are fundamental differences in breast tumors of CHEK2:p.I157T and c.1100delC carriers. The poor prognosis associated with c.1100delC cannot be generalized to other CHEK2 mutations.
claims array · 2 items
[0] object · 6 fields
id
claim-method
statement
Similarly, we investigated the p.I157T associated risk of early death, breast cancer-associated death, distant metastasis, locoregional relapse and second breast cancer using Cox proportional hazards models.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:27716369
locator
sections[0] "Abstract" paragraph 2
quote
Similarly, we investigated the p.I157T associated risk of early death, breast cancer-associated death, distant metastasis, locoregional relapse and second breast cancer using Cox proportional hazards models.
state
complete
[1] object · 6 fields
id
claim-data-access
statement
The dataset supporting the conclusions of this article is available in the Gene Expression Omnibus (GEO) repository, GEO: GSE24450, http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE24450.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:27716369
locator
sections[19] "ack" paragraph 1
quote
The dataset supporting the conclusions of this article is available in the Gene Expression Omnibus (GEO) repository, GEO: GSE24450, http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE24450.
state
complete
gaps array · 0 items
experiment object · 8 fields
state
partial
objective
Using Cox proportional hazards regression on survival and genotype data from 26,801 European female breast cancer patients recruited through 15 Breast Cancer Association Consortium studies, the paper found that p.I157T was not associated with increased risk of early death, breast cancer-associated death, or distant metastasis relapse, and that prognosis differed significantly between p.I157T and c.1100delC carriers.
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate from the source
kind
other
state
complete
blocked_on
null
description
The claim, method and evidence span published with the source article.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:27716369
outputs array · 1 item
[0]
the published estimate and its evidence
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data from the named repository
kind
data-preparation
state
blocked
blocked_on
data:accession_absent
description
The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.
parameters object · 0 fields
inputs array · 0 items
outputs array · 1 item
[0]
the source data with its repository provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the published analysis
kind
analysis
state
complete
blocked_on
null
description
Apply the paper's statistical method to the resolved series and compare the result with the published target.
parameters object · 0 fields
inputs array · 0 items
outputs array · 1 item
[0]
the replicated result and its comparison
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 1 item
[0]
step:obtain_source_data blocked on data:accession_absent
data object · 3 fields
state
partial
assets array · 5 items
[0] object · 15 fields
id
source:pmid:27716369
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.1186/s13058-016-0758-5
sha256
sha256:acf94cb8cecc4529c3b29d95e9abc7ec631323c32d39b0835bc9a6cc7d05a1a0
bytes
49197
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.1186/s13058-016-0758-5
version
null
note
Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.
structure object · 4 fields
pmcid
PMC5048645
source
europe_pmc_fulltext
coverage
whole_body_without_references
text_hash_scope
rendered_section_body
[1] object · 16 fields
id
asset:table:pmid:27716369:1
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:7f594784af71afcf97b98e76cb123a03e26ae57f139e5bb09931605456fe970b
bytes
3839
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[3]/table-wrap[1]#Tab1
version
null
note
Tumor characteristics of the BCAC study subjects
structure object · 5 fields
pmcid
PMC5048645
section_index
3
section_title
Study subjects for survival and pathology analyses
row_count
96
column_count
8
table object · 8 fields
label
Table 1
caption
Tumor characteristics of the BCAC study subjects
rows array · 96 items
[0] array · 7 items
[0]
[1]
Non-carriers
[2]
p.I157T carriers
[3]
c.1100delC carriers
[4]
p value (I157T/nc)
[5]
p value (I157T/1100delC)
[6]
p value (1100delC/nc)
[1] array · 8 items
[0]
ER
[1]
Negative
[2]
4595
[3]
85
[4]
26
[5]
0.00046
[6]
0.61
[7]
0.0015
[2] array · 3 items
[0]
20.2 %
[1]
15.5 %
[2]
11.2 %
[3] array · 4 items
[0]
Positive
[1]
18,179
[2]
462
[3]
207
[4] array · 3 items
[0]
79.8 %
[1]
84.5 %
[2]
88.8 %
[5] array · 7 items
[0]
Missing
[1]
3166
[2]
43
[3]
38
[4]
[5]
[6]
[6] array · 3 items
[0]
12.2 %
[1]
7.3 %
[2]
14.0 %
[7] array · 8 items
[0]
PR
[1]
Negative
[2]
6397
[3]
147
[4]
44
[5]
0.0034
[6]
0.90
[7]
0.0045
[8] array · 3 items
[0]
32.7 %
[1]
28.5 %
[2]
23.3 %
[9] array · 4 items
[0]
Positive
[1]
13,173
[2]
368
[3]
145
[10] array · 3 items
[0]
67.3 %
[1]
71.5 %
[2]
76.7 %
[11] array · 7 items
[0]
Missing
[1]
6370
[2]
75
[3]
82
[4]
[5]
[6]
[12] array · 3 items
[0]
24.6 %
[1]
12.7 %
[2]
30.3 %
[13] array · 8 items
[0]
Her2
[1]
Negative
[2]
8220
[3]
231
[4]
95
[5]
0.68
[6]
0.10
[7]
0.24
[14] array · 3 items
[0]
84.7 %
[1]
83.7 %
[2]
81.9 %
[15] array · 4 items
[0]
Positive
[1]
1483
[2]
45
[3]
21
[16] array · 3 items
[0]
15.3 %
[1]
16.3 %
[2]
18.1 %
[17] array · 7 items
[0]
Missing
[1]
16,237
[2]
314
[3]
155
[4]
[5]
[6]
[18] array · 3 items
[0]
62.6 %
[1]
53.2 %
[2]
57.2 %
[19] array · 8 items
[0]
EGFR
[1]
Negative
[2]
3841
[3]
122
[4]
62
[5]
0.21
[6]
0.26
[7]
0.034
[20] array · 3 items
[0]
89.6 %
[1]
90.4 %
[2]
96.9 %
[21] array · 4 items
[0]
Positive
[1]
448
[2]
13
[3]
2
[22] array · 3 items
[0]
10.4 %
[1]
9.6 %
[2]
3.1 %
[23] array · 7 items
[0]
Missing
[1]
21,651
[2]
455
[3]
207
[4]
[5]
[6]
[24] array · 3 items
[0]
83.5 %
[1]
77.1 %
[2]
76.4 %
[25] array · 8 items
[0]
CK5/6
[1]
Negative
[2]
4734
[3]
143
[4]
80
[5]
0.30
[6]
0.29
[7]
0.19
[26] array · 3 items
[0]
87.9 %
[1]
88.3 %
[2]
92.0 %
[27] array · 4 items
[0]
Positive
[1]
652
[2]
19
[3]
7
[28] array · 3 items
[0]
12.1 %
[1]
11.7 %
[2]
8.0 %
[29] array · 7 items
[0]
Missing
[1]
20,554
[2]
428
[3]
184
[4]
[5]
[6]
[30] array · 3 items
[0]
79.2 %
[1]
72.5 %
[2]
67.9 %
[31] array · 8 items
[0]
TP53
[1]
Negative
[2]
3755
[3]
144
[4]
88
[5]
0.00048
[6]
0.21
[7]
0.16
[32] array · 3 items
[0]
81.6 %
[1]
90.6 %
[2]
86.3 %
[33] array · 4 items
[0]
Positive
[1]
847
[2]
15
[3]
14
[34] array · 3 items
[0]
18.4 %
[1]
9.4 %
[2]
13.7 %
[35] array · 7 items
[0]
Missing
[1]
21,338
[2]
431
[3]
169
[4]
[5]
[6]
[36] array · 3 items
[0]
82.3 %
[1]
73.1 %
[2]
62.4 %
[37] array · 8 items
[0]
Tumor size (ordinal)
[1]
<20 mm
[2]
14,949
[3]
340
[4]
149
[5]
0.29
[6]
0.33
[7]
0.83
[38] array · 3 items
[0]
65.6 %
[1]
65.6 %
[2]
62.6 %
[39] array · 4 items
[0]
20–50 mm
[1]
6953
[2]
162
[3]
82
[40] array · 3 items
[0]
30.5 %
[1]
31.3 %
[2]
34.5 %
[41] array · 4 items
[0]
>50 mm
[1]
876
[2]
16
[3]
7
[42] array · 3 items
[0]
3.8 %
[1]
3.1 %
[2]
2.9 %
[43] array · 7 items
[0]
Missing
[1]
3162
[2]
72
[3]
33
[4]
[5]
[6]
[44] array · 3 items
[0]
12.2 %
[1]
12.2 %
[2]
12.2 %
[45] array · 8 items
[0]
Lymph node status
[1]
Negative
[2]
13,144
[3]
320
[4]
125
[5]
0.94
[6]
0.91
[7]
0.64
[46] array · 3 items
[0]
62.0 %
[1]
60.4 %
[2]
57.6 %
[47] array · 4 items
[0]
Positive
[1]
8070
[2]
210
[3]
92
[48] array · 3 items
[0]
38.0 %
[1]
39.6 %
[2]
42.4 %
[49] array · 7 items
[0]
Missing
[1]
4726
[2]
60
[3]
54
[4]
[5]
[6]
[50] array · 3 items
[0]
18.2 %
[1]
10.2 %
[2]
19.9 %
[51] array · 8 items
[0]
Grade (ordinal)
[1]
1
[2]
4916
[3]
132
[4]
38
[5]
0.00023
[6]
0.0030
[7]
0.38
[52] array · 3 items
[0]
22.5 %
[1]
26.7 %
[2]
17.4 %
[53] array · 4 items
[0]
2
[1]
10,817
[2]
266
[3]
127
[54] array · 3 items
[0]
49.6 %
[1]
53.7 %
[2]
58.0 %
[55] array · 7 items
[0]
3
[1]
6089
[2]
97
[3]
54
[4]
[5]
[6]
[56] array · 3 items
[0]
27.9 %
[1]
19.6 %
[2]
24.7 %
[57] array · 7 items
[0]
Missing
[1]
4118
[2]
95
[3]
52
[4]
[5]
[6]
[58] array · 3 items
[0]
15.9 %
[1]
16.1 %
[2]
19.2 %
[59] array · 8 items
[0]
Histological type
[1]
Ductal
[2]
14,133
[3]
273
[4]
193
[5]
0.0044*
[6]
0.0010#
[7]
0.67#
[60] array · 3 items
[0]
72.7 %
[1]
60.0 %
[2]
76.9 %
[61] array · 4 items
[0]
Lobular
[1]
2966
[2]
100
[3]
36
[62] array · 3 items
[0]
15.3 %
[1]
22.0 %
[2]
14.3 %
[63] array · 4 items
[0]
Mixed (ductal and lobular)
[1]
455
[2]
26
[3]
4
[64] array · 3 items
[0]
2.5 %
[1]
6.0 %
[2]
1.7 %
[65] array · 4 items
[0]
Tubular
[1]
271
[2]
17
[3]
2
[66] array · 3 items
[0]
1.5 %
[1]
4.0 %
[2]
0.7 %
[67] array · 4 items
[0]
Medullary
[1]
177
[2]
4
[3]
3
[68] array · 3 items
[0]
1.0 %
[1]
0.9 %
[2]
1.7 %
[69] array · 4 items
[0]
Mucinous
[1]
213
[2]
9
[3]
3
[70] array · 3 items
[0]
1.2 %
[1]
2.1 %
[2]
1.4 %
[71] array · 4 items
[0]
Papillary
[1]
55
[2]
1
[3]
1
[72] array · 3 items
[0]
0.3 %
[1]
0.2 %
[2]
1.8 %
[73] array · 7 items
[0]
Missing†
[1]
7670
[2]
160
[3]
29
[4]
[5]
[6]
[74] array · 3 items
[0]
29.6 %
[1]
27.1 %
[2]
10.7 %
[75] array · 8 items
[0]
Subtype‡
[1]
LumA (ER+, PR+, Her2-)
[2]
5415
[3]
164
[4]
72
[5]
0.00089
[6]
0.46
[7]
0.0087
[76] array · 3 items
[0]
58.9 %
[1]
63.6 %
[2]
65.5 %
[77] array · 4 items
[0]
LumB (ER+, PR-, Her2- or ER+, Her2+)
[1]
1939
[2]
62
[3]
30
[78] array · 3 items
[0]
21.1 %
[1]
24.0 %
[2]
27.3 %
[79] array · 4 items
[0]
Basal (ER-, PR-, Her2-)
[1]
1306
[2]
16
[3]
4
[80] array · 3 items
[0]
14.2 %
[1]
6.2 %
[2]
3.6 %
[81] array · 4 items
[0]
Her2-positive (ER-, PR-, Her2+)
[1]
536
[2]
16
[3]
4
[82] array · 3 items
[0]
5.8 %
[1]
6.2 %
[2]
3.6 %
[83] array · 7 items
[0]
Missing
[1]
16,744
[2]
332
[3]
161
[4]
[5]
[6]
[84] array · 3 items
[0]
64.5 %
[1]
56.3 %
[2]
59.4 %
[85] array · 8 items
[0]
AGE cat (ordinal)
[1]
50 or younger
[2]
6932
[3]
162
[4]
101
[5]
0.99
[6]
0.0037
[7]
0.0029
[86] array · 3 items
[0]
27.0 %
[1]
27.8 %
[2]
37.3 %
[87] array · 4 items
[0]
Older than 50 and not more than 70
[1]
16,083
[2]
344
[3]
151
[88] array · 3 items
[0]
62.6 %
[1]
59.0 %
[2]
55.7 %
[89] array · 4 items
[0]
Older than 70
[1]
2674
[2]
77
[3]
19
[90] array · 3 items
[0]
10.4 %
[1]
13.2 %
[2]
7.0 %
[91] array · 7 items
[0]
Missing
[1]
251
[2]
7
[3]
0
[4]
[5]
[6]
[92] array · 3 items
[0]
1.0 %
[1]
1.2 %
[2]
0.0 %
[93] array · 8 items
[0]
AGE
[1]
Mean
[2]
57.1
[3]
57.9
[4]
54.3
[5]
0.41
[6]
0.028
[7]
0.024
[94] array · 4 items
[0]
St.dev.
[1]
10.8
[2]
11.1
[3]
11.0
[95] array · 8 items
[0]
Total
[1]
[2]
25,940
[3]
590
[4]
271
[5]
[6]
[7]
locator
section[3]/table-wrap[1]#Tab1
[2] object · 16 fields
id
asset:table:pmid:27716369:2
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:7e87bf537ac23896155726d0a5098f82e6bdb92e425eb6ee6257f33a555d926f
bytes
678
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[11]/table-wrap[1]#Tab2
version
null
note
Phenotypic classification of breast tumors from ten carriers of p.I157T
structure object · 5 fields
pmcid
PMC5048645
section_index
11
section_title
Breast cancer subtypes
row_count
11
column_count
4
table object · 8 fields
label
Table 2
caption
Phenotypic classification of breast tumors from ten carriers of p.I157T
rows array · 11 items
[0] array · 4 items
[0]
[1]
Intrinsic subtype PAM50
[2]
IHC subtype St Gallen 2013 criteria
[3]
Histological type
[1] array · 4 items
[0]
HEL_045
[1]
Normal
[2]
LumA
[3]
Lobular
[2] array · 4 items
[0]
HEL_055
[1]
LumB
[2]
LumB
[3]
Ductal
[3] array · 4 items
[0]
HEL_086
[1]
LumA
[2]
LumA
[3]
Lobular
[4] array · 4 items
[0]
HEL_126
[1]
LumA
[2]
Basal
[3]
Ductal
[5] array · 4 items
[0]
HEL_128
[1]
LumA
[2]
LumB
[3]
Ductal
[6] array · 4 items
[0]
HEL_131
[1]
Basal
[2]
Her2pos
[3]
In situ
[7] array · 4 items
[0]
HEL_144
[1]
Normal
[2]
LumB
[3]
Lobular
[8] array · 4 items
[0]
HEL_150
[1]
Basal
[2]
LumB
[3]
Ductal
[9] array · 4 items
[0]
HEL_163
[1]
LumB
[2]
LumB
[3]
Ductal
[10] array · 4 items
[0]
HEL_174
[1]
Normal
[2]
LumA
[3]
Lobular
locator
section[11]/table-wrap[1]#Tab2
[3] object · 16 fields
id
asset:table:pmid:27716369:3
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:52e303b4aebb6da6804436fa908d7fded35cbffc0fa4dc5cb7165d31810a51c6
bytes
2904
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[12]/table-wrap[1]#Tab3
version
null
note
Risk of death or disease recurrence associated with CHEK2:p.I157T
structure object · 5 fields
pmcid
PMC5048645
section_index
12
section_title
Patient survival
row_count
36
column_count
7
table object · 8 fields
label
Table 3
caption
Risk of death or disease recurrence associated with CHEK2:p.I157T
rows array · 36 items
[0] array · 3 items
[0]
(a) All breast cancer patients
[1]
Univariate analysis
[2]
Adjusted analysis
[1] array · 6 items
[0]
I157T/nc
[1]
I157T/1100delC
[2]
1100delc/nc
[3]
I157T/nc
[4]
I157T/1100delC
[5]
1100delC/nc
[2] array · 7 items
[0]
Early death
[1]
0.85 [0.68 - 1.07]
[2]
0.74 [0.50 - 1.09]
[3]
1.28 [1.00 - 1.64]
[4]
0.80 [0.60 - 1.07]
[5]
0.51 [0.29 - 0.90]
[6]
1.32 [0.94 - 1.86]
[3] array · 6 items
[0]
0.16
[1]
0.12
[2]
0.054
[3]
0.13
[4]
0.0190
[5]
0.11
[4] array · 7 items
[0]
Breast cancer-specific death
[1]
0.85 [0.60 - 1.20]
[2]
0.64 [0.37 - 1.12]
[3]
1.44 [1.04 - 2.00]
[4]
0.93 [0.62 - 1.40]
[5]
0.46 [0.21 - 1.03]
[6]
1.25 [0.78 - 2.00]
[5] array · 6 items
[0]
0.36
[1]
0.12
[2]
0.030
[3]
0.73
[4]
0.058
[5]
0.36
[6] array · 7 items
[0]
Distant metastasis relapse
[1]
1.04 [0.79 - 1.37]
[2]
0.66 [0.38 - 1.14]
[3]
1.38 [0.90 - 2.11]
[4]
1.05 [0.75 - 1.47]
[5]
0.62 [0.31 - 1.23]
[6]
1.37 [0.83 - 2.26]
[7] array · 6 items
[0]
0.79
[1]
0.13
[2]
0.14
[3]
0.76
[4]
0.17
[5]
0.22
[8] array · 7 items
[0]
Locoregional relapse
[1]
1.43 [0.92 - 2.23]
[2]
0.81 [0.58 - 1.13]
[3]
2.07 [1.16 - 3.69]
[4]
1.62 [0.99 - 2.66]
[5]
0.91 [0.33 - 2.52]
[6]
1.26 [0.59 - 2.70]
[9] array · 6 items
[0]
0.11
[1]
0.21
[2]
0.014
[3]
0.056
[4]
0.85
[5]
0.55
[10] array · 7 items
[0]
Second breast cancer
[1]
1.54 [0.85 - 2.78]
[2]
0.69 [0.47 - 1.03]
[3]
2.88 [1.68 - 4.98]
[4]
2.03 [1.05 - 3.92]
[5]
0.69 [0.42 - 1.13]
[6]
3.62 [1.82 - 7.21]
[11] array · 6 items
[0]
0.15
[1]
0.070
[2]
0.00015
[3]
0.035
[4]
0.14
[5]
0.00026
[12] array · 3 items
[0]
(b) Patients with ER+ breast cancer
[1]
Univariate analysis
[2]
Adjusted analysis
[13] array · 6 items
[0]
I157T/nc
[1]
I157T/1100delC
[2]
1100delc/nc
[3]
I157T/nc
[4]
I157T/1100delC
[5]
1100delC/nc
[14] array · 7 items
[0]
Early death
[1]
0.81 [0.61 - 1.07]
[2]
0.62 [0.39 - 0.99]
[3]
1.32 [0.98 - 1.78]
[4]
0.77 [0.55 - 1.07]
[5]
0.46 [0.25 - 0.85]
[6]
1.52 [1.06 - 2.17]
[15] array · 6 items
[0]
0.14
[1]
0.044
[2]
0.067
[3]
0.12
[4]
0.013
[5]
0.022
[16] array · 7 items
[0]
Breast cancer-specific death
[1]
0.80 [0.51 - 1.23]
[2]
0.47 [0.23 - 0.96]
[3]
1.46 [0.96 - 2.22]
[4]
0.80 [0.49 - 1.32]
[5]
0.33 [0.13 - 0.84]
[6]
1.50 [0.92 - 2.45]
[17] array · 6 items
[0]
0.30
[1]
0.038
[2]
0.074
[3]
0.39
[4]
0.019
[5]
0.10
[18] array · 7 items
[0]
Distant metastasis relapse
[1]
1.00 [0.71 - 1.40]
[2]
0.55 [0.29 - 1.02]
[3]
1.58 [0.99 - 2.54]
[4]
1.03 [0.70 - 1.51]
[5]
0.56 [0.26 -1.19]
[6]
1.61 [0.94 - 2.77]
[19] array · 6 items
[0]
0.98
[1]
0.057
[2]
0.056
[3]
0.88
[4]
0.13
[5]
0.083
[20] array · 7 items
[0]
Locoregional relapse
[1]
1.46 [0.86 - 2.47]
[2]
0.77 [0.52 - 1.14]
[3]
2.33 [1.19 - 4.57]
[4]
1.58 [0.90 - 2.79]
[5]
0.93 [0.29 - 2.98]
[6]
1.08 [0.44 - 2.66]
[21] array · 6 items
[0]
0.16
[1]
0.19
[2]
0.014
[3]
0.11
[4]
0.90
[5]
0.87
[22] array · 7 items
[0]
Second breast cancer
[1]
1.33 [0.64 - 2.75]
[2]
0.58 [0.37 - 0.92]
[3]
4.09 [2.31 - 7.26]
[4]
1.81 [0.82 - 3.96]
[5]
0.61 [0.36 - 1.04]
[6]
4.39 [2.17 - 8.87]
[23] array · 6 items
[0]
0.44
[1]
0.019
[2]
1.4E-06
[3]
0.14
[4]
0.067
[5]
3.8E-05
[24] array · 3 items
[0]
(c) Patients with lobular breast cancer
[1]
Univariate analysis
[2]
[25] array · 1 item
[0]
I157T/nc
[26] array · 2 items
[0]
Early death
[1]
0.67 [0.39 - 1.15]
[27] array · 1 item
[0]
0.14
[28] array · 2 items
[0]
Breast cancer-specific death
[1]
0.91 [0.46 - 1.80]
[29] array · 1 item
[0]
0.79
[30] array · 2 items
[0]
Distant metastasis relapse
[1]
0.87 [0.48 - 1.57]
[31] array · 1 item
[0]
0.64
[32] array · 2 items
[0]
Locoregional relapse
[1]
2.45 [0.95 - 6.34]
[33] array · 1 item
[0]
0.065
[34] array · 2 items
[0]
Second breast cancer
[1]
1.92 [0.57 - 6.49]
[35] array · 1 item
[0]
0.29
locator
section[12]/table-wrap[1]#Tab3
[4] object · 16 fields
id
asset:table:pmid:27716369:4
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:2e8816a6a370b241fe0d9c52cd5c54c0d73f2bf3654adb5a7bd073c4da8663f4
bytes
1762
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[13]/table-wrap[1]#Tab4
version
null
note
Differentially expressed genes in breast tumors of p.I157T carriers when compared to non-carrier tumors
structure object · 5 fields
pmcid
PMC5048645
section_index
13
section_title
P.I157T associated differentially expressed genes
row_count
22
column_count
5
table object · 8 fields
label
Table 4
caption
Differentially expressed genes in breast tumors of p.I157T carriers when compared to non-carrier tumors
rows array · 22 items
[0] array · 5 items
[0]
Gene ID
[1]
Symbol
[2]
Description
[3]
logFC
[4]
p value
[1] array · 5 items
[0]
11283
[1]
CYP4F8
[2]
Cytochrome P450, family 4, subfamily F, polypeptide 8
[3]
1.10
[4]
0.00026
[2] array · 5 items
[0]
1289
[1]
COL5A1
[2]
Collagen, type V, alpha 1
[3]
1.24
[4]
0.00049
[3] array · 5 items
[0]
1292
[1]
COL6A2
[2]
Collagen, type VI, alpha 2
[3]
0.90
[4]
0.00056
[4] array · 5 items
[0]
56265
[1]
CPXM1
[2]
Carboxypeptidase X (M14 family), member 1
[3]
1.04
[4]
0.00063
[5] array · 5 items
[0]
1277
[1]
COL1A1
[2]
Collagen, type I, alpha 1
[3]
1.25
[4]
0.0011
[6] array · 5 items
[0]
23452
[1]
ANGPTL2
[2]
Angiopoietin-like 2
[3]
0.85
[4]
0.0020
[7] array · 5 items
[0]
5118
[1]
PCOLCE
[2]
Procollagen C-endopeptidase enhancer
[3]
0.90
[4]
0.0021
[8] array · 5 items
[0]
284297
[1]
SSC5D
[2]
Scavenger receptor cysteine rich family, 5 domains
[3]
0.84
[4]
0.0025
[9] array · 5 items
[0]
25903
[1]
OLFML2B
[2]
Olfactomedin-like 2B
[3]
0.88
[4]
0.0026
[10] array · 5 items
[0]
27239
[1]
GPR162
[2]
G protein-coupled receptor 162
[3]
0.73
[4]
0.0026
[11] array · 5 items
[0]
5654
[1]
HTRA1
[2]
HtrA serine peptidase 1
[3]
0.96
[4]
0.0027
[12] array · 5 items
[0]
9315
[1]
NREP
[2]
Neuronal regeneration-related protein
[3]
0.78
[4]
0.0028
[13] array · 5 items
[0]
1278
[1]
COL1A2
[2]
Collagen, type I, alpha 2
[3]
1.02
[4]
0.0046
[14] array · 5 items
[0]
8510
[1]
MMP23B
[2]
Matrix metallopeptidase 23B
[3]
0.73
[4]
0.0055
[15] array · 5 items
[0]
114902
[1]
C1QTNF5
[2]
C1q and tumor necrosis factor-related protein 5
[3]
0.77
[4]
0.0057
[16] array · 5 items
[0]
6678
[1]
SPARC
[2]
Secreted protein, acidic, cysteine-rich (osteonectin)
[3]
0.88
[4]
0.0073
[17] array · 5 items
[0]
9622
[1]
KLK4
[2]
Kallikrein-related peptidase 4
[3]
1.03
[4]
0.0082
[18] array · 5 items
[0]
1291
[1]
COL6A1
[2]
Collagen, type VI, alpha 1
[3]
0.92
[4]
0.0084
[19] array · 5 items
[0]
1307
[1]
COL16A1
[2]
Collagen, type XVI, alpha 1
[3]
0.73
[4]
0.0090
[20] array · 5 items
[0]
1290
[1]
COL5A2
[2]
Collagen, type V, alpha 2
[3]
0.93
[4]
0.0095
[21] array · 5 items
[0]
7070
[1]
THY1
[2]
Thy-1 cell surface antigen
[3]
0.88
[4]
0.0098
locator
section[13]/table-wrap[1]#Tab4
gaps array · 0 items
analysis object · 4 fields
state
complete
methods array · 1 item
[0] object · 10 fields
id
method-1
family
survival_analysis
specific
cox_proportional_hazards
label
Survival analysis
dsl_operations array · 1 item
[0]
cox_ph
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
1
band
verbatim
quote
Similarly, we investigated the p.I157T associated risk of early death, breast cancer-associated death, distant metastasis, locoregional relapse and second breast cancer using Cox proportional hazards models.
targets array · 0 items
gaps array · 0 items
capability object · 3 fields
state
complete
requirements array · 1 item
[0] object · 6 fields
capability_id
capability:computational_analysis
label
Computational analysis platform
assay_families array · 9 items
[0]
meta_analysis
[1]
machine_learning
[2]
survival_analysis
[3]
statistical_regression
[4]
pca
[5]
molecular_docking
[6]
network_analysis
[7]
differential_expression
[8]
gwas
candidate
Automated Assays Laravel application and simulated adapters
gaps array · 0 items
readiness object · 8 fields
state
blocked
tier
R4
blocked_on
data:accession_absent
axes object · 3 fields
method object · 5 fields
tier
R1
expressible
true
required_operations array · 1 item
[0]
cox_ph
missing_operations array · 0 items
basis
The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: cox_proportional_hazards.
capability object · 4 fields
tier
R1
capability_id
capability:computational_analysis
availability_state
owned
basis
The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here.
data object · 6 fields
tier
R4
reachable
false
accessions array · 1 item
[0]
GEO: GSE24450
resolved_accessions array · 0 items
statements array · 1 item
[0]
The dataset supporting the conclusions of this article is available in the Gene Expression Omnibus (GEO) repository, GEO: GSE24450, http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE24450.
basis
The paper names GEO: GSE24450, but the accession does not resolve in the repository (no reason recorded), so the data cannot be reached from here. No dataset was downloaded and no licence was read.
can_run object · 3 fields
dsl_operations array · 1 item
[0]
cox_ph
assets array · 5 items
[0]
source:pmid:27716369
[1]
asset:table:pmid:27716369:1
[2]
asset:table:pmid:27716369:2
[3]
asset:table:pmid:27716369:3
[4]
asset:table:pmid:27716369:4
steps array · 1 item
[0]
run_analysis
must_build object · 5 fields
dsl_operations array · 0 items
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
[0]
data:geo:None
gaps array · 1 item
[0]
data:accession_absent
review object · 5 fields
state
partial
machine_critique object · 5 fields
kind
extraction_review
reader object · 5 fields
model
MiniMax-M3.1-Flash
provider
minimax
provider_family
minimax
read_at
2026-10-31T18:29:32Z
independence
same_provider
evidence_check object · 2 fields
method
verbatim
availability
verbatim
calls
8
usage object · 3 fields
prompt_tokens
105763
completion_tokens
4347
cached_tokens
1560
stages array · 1 item
[0] object · 4 fields
id
extraction
state
complete
reader
MiniMax-M3.1-Flash
provider
minimax
gaps array · 3 items
[0]
review.independent_reader
[1]
review.machine_critique
[2]
review.human_critique
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 3 items
[0] object · 3 fields
id
pmid:27716369
type
paper
label
pmid:27716369
[1] object · 3 fields
id
source:pmid:27716369
type
manuscript
label
PMID 27716369 full text
[2] object · 3 fields
id
data:geo:None
type
dataset
label
GEO None
activities array · 3 items
[0] object · 4 fields
id
activity-reading-sci-2026-11-01
type
classification
used array · 3 items
[0] object · 3 fields
id
pmid:27716369
type
paper
label
pmid:27716369
[1] object · 3 fields
id
source:pmid:27716369
type
manuscript
label
PMID 27716369 full text
[2] object · 3 fields
id
data:geo:None
type
dataset
label
GEO None
agent
agent:corpus-assay-engine
[1] object · 4 fields
id
activity-read-27716369
type
extraction
used array · 1 item
[0]
source:pmid:27716369
agent
agent:minimax-reader
[2] object · 4 fields
id
activity-resolve-None
type
accession_resolution
used array · 1 item
[0]
data:geo:None
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
[1] object · 3 fields
id
agent:minimax-reader
type
software
label
MiniMax literature reader
source_run_id
reading-sci-2026-11-01
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:27716369
parent_hash
sha256:5bb2304edac4fe5def58fd66c0c5b5ac30a720ff2db7610deb0ef20f4cde105f
fork_of
null
gaps array · 5 items
[0]
execution.not_run
[1]
review.human_critique
[2]
review.independent_reader
[3]
review.machine_critique
[4]
step:obtain_source_data blocked on data:accession_absent
assays array · 1 item
[0] object · 11 fields
role
analysis
definition_id
survival_analysis
definition_version
f2132e96ae6c7a4e
required_operations array · 1 item
[0]
cox_ph
support_state
supported
source_hashes object · 1 field
dsl_catalogue
f2132e96ae6c7a4e
evidence array · 1 item
[0]
Similarly, we investigated the p.I157T associated risk of early death, breast cancer-associated death, distant metastasis, locoregional relapse and second breast cancer using Cox proportional hazards models.
order_basis
analysis_only
id
assay:1
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:27716369", "kind": "science-record", "revision": 6, "content_hash": "sha256:87405e2323f281a6ff7b41f90f56cd6eec39ca96509b1a4cfef82f55dfa454da", "created_at": "2026-11-01T15:40:20Z", "updated_at": "2026-11-01T21:20:40Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association Consortium.", "doi": "10.1186/s13058-016-0758-5", "pmid": "27716369", "authors": ["Taru A Muranen", "Carl Blomqvist", "Thilo Dörk", "Anna Jakubowska", "Päivi Heikkilä", "Rainer Fagerholm", "Dario Greco", "Kristiina Aittomäki", "Stig E Bojesen", "Mitul Shah", "Alison M Dunning", "Valerie Rhenius", "Per Hall", "Kamila Czene", "Judith S Brand", "Hatef Darabi", "Jenny Chang-Claude", "Anja Rudolph", "Børge G Nordestgaard", "Fergus J Couch", "Steven N Hart", "Jonine Figueroa", "Montserrat García-Closas", "Peter A Fasching", "Matthias W Beckmann", "Jingmei Li", "Jianjun Liu", "Irene L Andrulis", "Robert Winqvist", "Katri Pylkäs", "Arto Mannermaa", "Vesa Kataja", "Annika Lindblom", "Sara Margolin", "Jan Lubinski", "Natalia Dubrowinskaja", "Manjeet K Bolla", "Joe Dennis", "Kyriaki Michailidou", "Qin Wang", "Douglas F Easton", "Paul D P Pharoah", "Marjanka K Schmidt", "Heli Nevanlinna"], "journal": "Breast cancer research : BCR", "year": 2016, "abstract": "BACKGROUND: P.I157T is a CHEK2 missense mutation associated with a modest increase in breast cancer risk. Previously, another CHEK2 mutation, the protein truncating c.1100delC has been associated with poor prognosis of breast cancer patients. Here, we have investigated patient survival and characteristics of breast tumors of germ line p.I157T carriers.\nMETHODS: We included in the analyses 26,801 European female breast cancer patients from 15 studies participating in the Breast Cancer Association Consortium. We analyzed the association between p.I157T and the clinico-pathological breast cancer characteristics by comparing the p.I157T carrier tumors to non-carrier and c.1100delC carrier tumors. Similarly, we investigated the p.I157T associated risk of early death, breast cancer-associated death, distant metastasis, locoregional relapse and second breast cancer using Cox proportional hazards models. Additionally, we explored the p.I157T-associated genomic gene expression profile using data from breast tumors of 183 Finnish female breast cancer patients (ten p.I157T carriers) (GEO: GSE24450). Differential gene expression analysis was performed using a moderated t test. Functional enrichment was investigated using the DAVID functional annotation tool and gene set enrichment analysis (GSEA). The tumors were classified into molecular subtypes according to the St Gallen 2013 criteria and the PAM50 gene expression signature.\nRESULTS: P.I157T was not associated with increased risk of early death, breast cancer-associated death or distant metastasis relapse, and there was a significant difference in prognosis associated with the two CHEK2 mutations, p.I157T and c.1100delC. Furthermore, p.I157T was associated with lobular histological type and clinico-pathological markers of good prognosis, such as ER and PR expression, low TP53 expression and low grade. Gene expression analysis suggested luminal A to be the most common subtype for p.I157T carriers and CDH1 (cadherin 1) target genes to be significantly enriched among genes, whose expression differed between p.I157T and non-carrier tumors.\nCONCLUSIONS: Our analyses suggest that there are fundamental differences in breast tumors of CHEK2:p.I157T and c.1100delC carriers. The poor prognosis associated with c.1100delC cannot be generalized to other CHEK2 mutations.", "claims": [{"id": "claim-method", "statement": "Similarly, we investigated the p.I157T associated risk of early death, breast cancer-associated death, distant metastasis, locoregional relapse and second breast cancer using Cox proportional hazards models.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:27716369", "locator": "sections[0] \"Abstract\" paragraph 2", "quote": "Similarly, we investigated the p.I157T associated risk of early death, breast cancer-associated death, distant metastasis, locoregional relapse and second breast cancer using Cox proportional hazards models."}], "state": "complete"}, {"id": "claim-data-access", "statement": "The dataset supporting the conclusions of this article is available in the Gene Expression Omnibus (GEO) repository, GEO: GSE24450, http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE24450.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:27716369", "locator": "sections[19] \"ack\" paragraph 1", "quote": "The dataset supporting the conclusions of this article is available in the Gene Expression Omnibus (GEO) repository, GEO: GSE24450, http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE24450."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "partial", "objective": "Using Cox proportional hazards regression on survival and genotype data from 26,801 European female breast cancer patients recruited through 15 Breast Cancer Association Consortium studies, the paper found that p.I157T was not associated with increased risk of early death, breast cancer-associated death, or distant metastasis relapse, and that prognosis differed significantly between p.I157T and c.1100delC carriers.", "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:27716369"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "blocked", "blocked_on": "data:accession_absent", "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": [], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": [], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": ["step:obtain_source_data blocked on data:accession_absent"]}, "data": {"state": "partial", "assets": [{"id": "source:pmid:27716369", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.1186/s13058-016-0758-5", "sha256": "sha256:acf94cb8cecc4529c3b29d95e9abc7ec631323c32d39b0835bc9a6cc7d05a1a0", "bytes": 49197, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.1186/s13058-016-0758-5", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC5048645", "source": "europe_pmc_fulltext", "coverage": "whole_body_without_references", "text_hash_scope": "rendered_section_body"}}, {"id": "asset:table:pmid:27716369:1", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:7f594784af71afcf97b98e76cb123a03e26ae57f139e5bb09931605456fe970b", "bytes": 3839, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[3]/table-wrap[1]#Tab1", "version": null, "note": "Tumor characteristics of the BCAC study subjects", "structure": {"pmcid": "PMC5048645", "section_index": 3, "section_title": "Study subjects for survival and pathology analyses", "row_count": 96, "column_count": 8}, "table": {"label": "Table 1", "caption": "Tumor characteristics of the BCAC study subjects", "rows": [["", "Non-carriers", "p.I157T carriers", "c.1100delC carriers", "p value (I157T/nc)", "p value (I157T/1100delC)", "p value (1100delC/nc)"], ["ER", "Negative", "4595", "85", "26", "0.00046", "0.61", "0.0015"], ["20.2 %", "15.5 %", "11.2 %"], ["Positive", "18,179", "462", "207"], ["79.8 %", "84.5 %", "88.8 %"], ["Missing", "3166", "43", "38", "", "", ""], ["12.2 %", "7.3 %", "14.0 %"], ["PR", "Negative", "6397", "147", "44", "0.0034", "0.90", "0.0045"], ["32.7 %", "28.5 %", "23.3 %"], ["Positive", "13,173", "368", "145"], ["67.3 %", "71.5 %", "76.7 %"], ["Missing", "6370", "75", "82", "", "", ""], ["24.6 %", "12.7 %", "30.3 %"], ["Her2", "Negative", "8220", "231", "95", "0.68", "0.10", "0.24"], ["84.7 %", "83.7 %", "81.9 %"], ["Positive", "1483", "45", "21"], ["15.3 %", "16.3 %", "18.1 %"], ["Missing", "16,237", "314", "155", "", "", ""], ["62.6 %", "53.2 %", "57.2 %"], ["EGFR", "Negative", "3841", "122", "62", "0.21", "0.26", "0.034"], ["89.6 %", "90.4 %", "96.9 %"], ["Positive", "448", "13", "2"], ["10.4 %", "9.6 %", "3.1 %"], ["Missing", "21,651", "455", "207", "", "", ""], ["83.5 %", "77.1 %", "76.4 %"], ["CK5/6", "Negative", "4734", "143", "80", "0.30", "0.29", "0.19"], ["87.9 %", "88.3 %", "92.0 %"], ["Positive", "652", "19", "7"], ["12.1 %", "11.7 %", "8.0 %"], ["Missing", "20,554", "428", "184", "", "", ""], ["79.2 %", "72.5 %", "67.9 %"], ["TP53", "Negative", "3755", "144", "88", "0.00048", "0.21", "0.16"], ["81.6 %", "90.6 %", "86.3 %"], ["Positive", "847", "15", "14"], ["18.4 %", "9.4 %", "13.7 %"], ["Missing", "21,338", "431", "169", "", "", ""], ["82.3 %", "73.1 %", "62.4 %"], ["Tumor size (ordinal)", "<20 mm", "14,949", "340", "149", "0.29", "0.33", "0.83"], ["65.6 %", "65.6 %", "62.6 %"], ["20–50 mm", "6953", "162", "82"], ["30.5 %", "31.3 %", "34.5 %"], [">50 mm", "876", "16", "7"], ["3.8 %", "3.1 %", "2.9 %"], ["Missing", "3162", "72", "33", "", "", ""], ["12.2 %", "12.2 %", "12.2 %"], ["Lymph node status", "Negative", "13,144", "320", "125", "0.94", "0.91", "0.64"], ["62.0 %", "60.4 %", "57.6 %"], ["Positive", "8070", "210", "92"], ["38.0 %", "39.6 %", "42.4 %"], ["Missing", "4726", "60", "54", "", "", ""], ["18.2 %", "10.2 %", "19.9 %"], ["Grade (ordinal)", "1", "4916", "132", "38", "0.00023", "0.0030", "0.38"], ["22.5 %", "26.7 %", "17.4 %"], ["2", "10,817", "266", "127"], ["49.6 %", "53.7 %", "58.0 %"], ["3", "6089", "97", "54", "", "", ""], ["27.9 %", "19.6 %", "24.7 %"], ["Missing", "4118", "95", "52", "", "", ""], ["15.9 %", "16.1 %", "19.2 %"], ["Histological type", "Ductal", "14,133", "273", "193", "0.0044*", "0.0010#", "0.67#"], ["72.7 %", "60.0 %", "76.9 %"], ["Lobular", "2966", "100", "36"], ["15.3 %", "22.0 %", "14.3 %"], ["Mixed (ductal and lobular)", "455", "26", "4"], ["2.5 %", "6.0 %", "1.7 %"], ["Tubular", "271", "17", "2"], ["1.5 %", "4.0 %", "0.7 %"], ["Medullary", "177", "4", "3"], ["1.0 %", "0.9 %", "1.7 %"], ["Mucinous", "213", "9", "3"], ["1.2 %", "2.1 %", "1.4 %"], ["Papillary", "55", "1", "1"], ["0.3 %", "0.2 %", "1.8 %"], ["Missing†", "7670", "160", "29", "", "", ""], ["29.6 %", "27.1 %", "10.7 %"], ["Subtype‡", "LumA (ER+, PR+, Her2-)", "5415", "164", "72", "0.00089", "0.46", "0.0087"], ["58.9 %", "63.6 %", "65.5 %"], ["LumB (ER+, PR-, Her2- or ER+, Her2+)", "1939", "62", "30"], ["21.1 %", "24.0 %", "27.3 %"], ["Basal (ER-, PR-, Her2-)", "1306", "16", "4"], ["14.2 %", "6.2 %", "3.6 %"], ["Her2-positive (ER-, PR-, Her2+)", "536", "16", "4"], ["5.8 %", "6.2 %", "3.6 %"], ["Missing", "16,744", "332", "161", "", "", ""], ["64.5 %", "56.3 %", "59.4 %"], ["AGE cat (ordinal)", "50 or younger", "6932", "162", "101", "0.99", "0.0037", "0.0029"], ["27.0 %", "27.8 %", "37.3 %"], ["Older than 50 and not more than 70", "16,083", "344", "151"], ["62.6 %", "59.0 %", "55.7 %"], ["Older than 70", "2674", "77", "19"], ["10.4 %", "13.2 %", "7.0 %"], ["Missing", "251", "7", "0", "", "", ""], ["1.0 %", "1.2 %", "0.0 %"], ["AGE", "Mean", "57.1", "57.9", "54.3", "0.41", "0.028", "0.024"], ["St.dev.", "10.8", "11.1", "11.0"], ["Total", "", "25,940", "590", "271", "", "", ""]], "row_count": 96, "column_count": 8, "numeric_cells": 340, "header_rows": 1, "locator": "section[3]/table-wrap[1]#Tab1"}}, {"id": "asset:table:pmid:27716369:2", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:7e87bf537ac23896155726d0a5098f82e6bdb92e425eb6ee6257f33a555d926f", "bytes": 678, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[11]/table-wrap[1]#Tab2", "version": null, "note": "Phenotypic classification of breast tumors from ten carriers of p.I157T", "structure": {"pmcid": "PMC5048645", "section_index": 11, "section_title": "Breast cancer subtypes", "row_count": 11, "column_count": 4}, "table": {"label": "Table 2", "caption": "Phenotypic classification of breast tumors from ten carriers of p.I157T", "rows": [["", "Intrinsic subtype PAM50", "IHC subtype St Gallen 2013 criteria", "Histological type"], ["HEL_045", "Normal", "LumA", "Lobular"], ["HEL_055", "LumB", "LumB", "Ductal"], ["HEL_086", "LumA", "LumA", "Lobular"], ["HEL_126", "LumA", "Basal", "Ductal"], ["HEL_128", "LumA", "LumB", "Ductal"], ["HEL_131", "Basal", "Her2pos", "In situ"], ["HEL_144", "Normal", "LumB", "Lobular"], ["HEL_150", "Basal", "LumB", "Ductal"], ["HEL_163", "LumB", "LumB", "Ductal"], ["HEL_174", "Normal", "LumA", "Lobular"]], "row_count": 11, "column_count": 4, "numeric_cells": 12, "header_rows": 1, "locator": "section[11]/table-wrap[1]#Tab2"}}, {"id": "asset:table:pmid:27716369:3", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:52e303b4aebb6da6804436fa908d7fded35cbffc0fa4dc5cb7165d31810a51c6", "bytes": 2904, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[12]/table-wrap[1]#Tab3", "version": null, "note": "Risk of death or disease recurrence associated with CHEK2:p.I157T", "structure": {"pmcid": "PMC5048645", "section_index": 12, "section_title": "Patient survival", "row_count": 36, "column_count": 7}, "table": {"label": "Table 3", "caption": "Risk of death or disease recurrence associated with CHEK2:p.I157T", "rows": [["(a) All breast cancer patients", "Univariate analysis", "Adjusted analysis"], ["I157T/nc", "I157T/1100delC", "1100delc/nc", "I157T/nc", "I157T/1100delC", "1100delC/nc"], ["Early death", "0.85 [0.68 - 1.07]", "0.74 [0.50 - 1.09]", "1.28 [1.00 - 1.64]", "0.80 [0.60 - 1.07]", "0.51 [0.29 - 0.90]", "1.32 [0.94 - 1.86]"], ["0.16", "0.12", "0.054", "0.13", "0.0190", "0.11"], ["Breast cancer-specific death", "0.85 [0.60 - 1.20]", "0.64 [0.37 - 1.12]", "1.44 [1.04 - 2.00]", "0.93 [0.62 - 1.40]", "0.46 [0.21 - 1.03]", "1.25 [0.78 - 2.00]"], ["0.36", "0.12", "0.030", "0.73", "0.058", "0.36"], ["Distant metastasis relapse", "1.04 [0.79 - 1.37]", "0.66 [0.38 - 1.14]", "1.38 [0.90 - 2.11]", "1.05 [0.75 - 1.47]", "0.62 [0.31 - 1.23]", "1.37 [0.83 - 2.26]"], ["0.79", "0.13", "0.14", "0.76", "0.17", "0.22"], ["Locoregional relapse", "1.43 [0.92 - 2.23]", "0.81 [0.58 - 1.13]", "2.07 [1.16 - 3.69]", "1.62 [0.99 - 2.66]", "0.91 [0.33 - 2.52]", "1.26 [0.59 - 2.70]"], ["0.11", "0.21", "0.014", "0.056", "0.85", "0.55"], ["Second breast cancer", "1.54 [0.85 - 2.78]", "0.69 [0.47 - 1.03]", "2.88 [1.68 - 4.98]", "2.03 [1.05 - 3.92]", "0.69 [0.42 - 1.13]", "3.62 [1.82 - 7.21]"], ["0.15", "0.070", "0.00015", "0.035", "0.14", "0.00026"], ["(b) Patients with ER+ breast cancer", "Univariate analysis", "Adjusted analysis"], ["I157T/nc", "I157T/1100delC", "1100delc/nc", "I157T/nc", "I157T/1100delC", "1100delC/nc"], ["Early death", "0.81 [0.61 - 1.07]", "0.62 [0.39 - 0.99]", "1.32 [0.98 - 1.78]", "0.77 [0.55 - 1.07]", "0.46 [0.25 - 0.85]", "1.52 [1.06 - 2.17]"], ["0.14", "0.044", "0.067", "0.12", "0.013", "0.022"], ["Breast cancer-specific death", "0.80 [0.51 - 1.23]", "0.47 [0.23 - 0.96]", "1.46 [0.96 - 2.22]", "0.80 [0.49 - 1.32]", "0.33 [0.13 - 0.84]", "1.50 [0.92 - 2.45]"], ["0.30", "0.038", "0.074", "0.39", "0.019", "0.10"], ["Distant metastasis relapse", "1.00 [0.71 - 1.40]", "0.55 [0.29 - 1.02]", "1.58 [0.99 - 2.54]", "1.03 [0.70 - 1.51]", "0.56 [0.26 -1.19]", "1.61 [0.94 - 2.77]"], ["0.98", "0.057", "0.056", "0.88", "0.13", "0.083"], ["Locoregional relapse", "1.46 [0.86 - 2.47]", "0.77 [0.52 - 1.14]", "2.33 [1.19 - 4.57]", "1.58 [0.90 - 2.79]", "0.93 [0.29 - 2.98]", "1.08 [0.44 - 2.66]"], ["0.16", "0.19", "0.014", "0.11", "0.90", "0.87"], ["Second breast cancer", "1.33 [0.64 - 2.75]", "0.58 [0.37 - 0.92]", "4.09 [2.31 - 7.26]", "1.81 [0.82 - 3.96]", "0.61 [0.36 - 1.04]", "4.39 [2.17 - 8.87]"], ["0.44", "0.019", "1.4E-06", "0.14", "0.067", "3.8E-05"], ["(c) Patients with lobular breast cancer", "Univariate analysis", ""], ["I157T/nc"], ["Early death", "0.67 [0.39 - 1.15]"], ["0.14"], ["Breast cancer-specific death", "0.91 [0.46 - 1.80]"], ["0.79"], ["Distant metastasis relapse", "0.87 [0.48 - 1.57]"], ["0.64"], ["Locoregional relapse", "2.45 [0.95 - 6.34]"], ["0.065"], ["Second breast cancer", "1.92 [0.57 - 6.49]"], ["0.29"]], "row_count": 36, "column_count": 7, "numeric_cells": 143, "header_rows": 0, "locator": "section[12]/table-wrap[1]#Tab3"}}, {"id": "asset:table:pmid:27716369:4", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:2e8816a6a370b241fe0d9c52cd5c54c0d73f2bf3654adb5a7bd073c4da8663f4", "bytes": 1762, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[13]/table-wrap[1]#Tab4", "version": null, "note": "Differentially expressed genes in breast tumors of p.I157T carriers when compared to non-carrier tumors", "structure": {"pmcid": "PMC5048645", "section_index": 13, "section_title": "P.I157T associated differentially expressed genes", "row_count": 22, "column_count": 5}, "table": {"label": "Table 4", "caption": "Differentially expressed genes in breast tumors of p.I157T carriers when compared to non-carrier tumors", "rows": [["Gene ID", "Symbol", "Description", "logFC", "p value"], ["11283", "CYP4F8", "Cytochrome P450, family 4, subfamily F, polypeptide 8", "1.10", "0.00026"], ["1289", "COL5A1", "Collagen, type V, alpha 1", "1.24", "0.00049"], ["1292", "COL6A2", "Collagen, type VI, alpha 2", "0.90", "0.00056"], ["56265", "CPXM1", "Carboxypeptidase X (M14 family), member 1", "1.04", "0.00063"], ["1277", "COL1A1", "Collagen, type I, alpha 1", "1.25", "0.0011"], ["23452", "ANGPTL2", "Angiopoietin-like 2", "0.85", "0.0020"], ["5118", "PCOLCE", "Procollagen C-endopeptidase enhancer", "0.90", "0.0021"], ["284297", "SSC5D", "Scavenger receptor cysteine rich family, 5 domains", "0.84", "0.0025"], ["25903", "OLFML2B", "Olfactomedin-like 2B", "0.88", "0.0026"], ["27239", "GPR162", "G protein-coupled receptor 162", "0.73", "0.0026"], ["5654", "HTRA1", "HtrA serine peptidase 1", "0.96", "0.0027"], ["9315", "NREP", "Neuronal regeneration-related protein", "0.78", "0.0028"], ["1278", "COL1A2", "Collagen, type I, alpha 2", "1.02", "0.0046"], ["8510", "MMP23B", "Matrix metallopeptidase 23B", "0.73", "0.0055"], ["114902", "C1QTNF5", "C1q and tumor necrosis factor-related protein 5", "0.77", "0.0057"], ["6678", "SPARC", "Secreted protein, acidic, cysteine-rich (osteonectin)", "0.88", "0.0073"], ["9622", "KLK4", "Kallikrein-related peptidase 4", "1.03", "0.0082"], ["1291", "COL6A1", "Collagen, type VI, alpha 1", "0.92", "0.0084"], ["1307", "COL16A1", "Collagen, type XVI, alpha 1", "0.73", "0.0090"], ["1290", "COL5A2", "Collagen, type V, alpha 2", "0.93", "0.0095"], ["7070", "THY1", "Thy-1 cell surface antigen", "0.88", "0.0098"]], "row_count": 22, "column_count": 5, "numeric_cells": 84, "header_rows": 1, "locator": "section[13]/table-wrap[1]#Tab4"}}], "gaps": []}, "analysis": {"state": "complete", "methods": [{"id": "method-1", "family": "survival_analysis", "specific": "cox_proportional_hazards", "label": "Survival analysis", "dsl_operations": ["cox_ph"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 1.0, "band": "verbatim", "quote": "Similarly, we investigated the p.I157T associated risk of early death, breast cancer-associated death, distant metastasis, locoregional relapse and second breast cancer using Cox proportional hazards models."}}], "targets": [], "gaps": []}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "blocked", "tier": "R4", "blocking_axis": "data", "blocked_on": "data:accession_absent", "axes": {"method": {"tier": "R1", "expressible": true, "required_operations": ["cox_ph"], "missing_operations": [], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: cox_proportional_hazards."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R4", "reachable": false, "accessions": ["GEO: GSE24450"], "resolved_accessions": [], "statements": ["The dataset supporting the conclusions of this article is available in the Gene Expression Omnibus (GEO) repository, GEO: GSE24450, http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE24450."], "basis": "The paper names GEO: GSE24450, but the accession does not resolve in the repository (no reason recorded), so the data cannot be reached from here. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": ["cox_ph"], "assets": ["source:pmid:27716369", "asset:table:pmid:27716369:1", "asset:table:pmid:27716369:2", "asset:table:pmid:27716369:3", "asset:table:pmid:27716369:4"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:None"]}, "gaps": ["data:accession_absent"]}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-10-31T18:29:32Z", "independence": "same_provider"}, "evidence_check": {"method": "verbatim", "availability": "verbatim"}, "calls": 8, "usage": {"prompt_tokens": 105763, "completion_tokens": 4347, "cached_tokens": 1560}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:27716369", "type": "paper", "label": "pmid:27716369"}, {"id": "source:pmid:27716369", "type": "manuscript", "label": "PMID 27716369 full text"}, {"id": "data:geo:None", "type": "dataset", "label": "GEO None"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:27716369", "type": "paper", "label": "pmid:27716369"}, {"id": "source:pmid:27716369", "type": "manuscript", "label": "PMID 27716369 full text"}, {"id": "data:geo:None", "type": "dataset", "label": "GEO None"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-27716369", "type": "extraction", "used": ["source:pmid:27716369"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-None", "type": "accession_resolution", "used": ["data:geo:None"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:27716369", "parent_hash": "sha256:5bb2304edac4fe5def58fd66c0c5b5ac30a720ff2db7610deb0ef20f4cde105f", "fork_of": null, "generation": 5}, "gaps": ["execution.not_run", "review.human_critique", "review.independent_reader", "review.machine_critique", "step:obtain_source_data blocked on data:accession_absent"], "assays": [{"role": "analysis", "definition_id": "survival_analysis", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": ["cox_ph"], "support_state": "supported", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 1.0, "evidence": ["Similarly, we investigated the p.I157T associated risk of early death, breast cancer-associated death, distant metastasis, locoregional relapse and second breast cancer using Cox proportional hazards models."], "order_basis": "analysis_only", "id": "assay:1"}]}